750 related articles for article (PubMed ID: 20728471)
21. Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication.
Yang X; Li H; Sun H; Fan H; Hu Y; Liu M; Li X; Tang H
J Virol; 2017 May; 91(10):. PubMed ID: 28148795
[TBL] [Abstract][Full Text] [Related]
22. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
[TBL] [Abstract][Full Text] [Related]
23. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
Tian H; He Z
Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
[TBL] [Abstract][Full Text] [Related]
24. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
25. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.
Xie HY; Xia WL; Zhang CC; Wu LM; Ji HF; Cheng Y; Zheng SS
Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNAs in hepatitis B virus-infected patients.
Ji F; Yang B; Peng X; Ding H; You H; Tien P
J Viral Hepat; 2011 Jul; 18(7):e242-51. PubMed ID: 21692939
[TBL] [Abstract][Full Text] [Related]
28. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line.
Konishi M; Wu CH; Wu GY
Hepatology; 2003 Oct; 38(4):842-50. PubMed ID: 14512871
[TBL] [Abstract][Full Text] [Related]
30. [Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV].
Liang WF; Liu ZH; Yang J; Luo KX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1374-5. PubMed ID: 17884782
[TBL] [Abstract][Full Text] [Related]
31. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro.
Nakazono K; Ito Y; Wu CH; Wu GY
Hepatology; 1996 Jun; 23(6):1297-303. PubMed ID: 8675142
[TBL] [Abstract][Full Text] [Related]
33. [Anti-HBV effect of targeted antisense RNA against HBV C gene].
Zhang J; Chen F; Zhong S; Tang K; Shi X; Wang M; Peng J
Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):169-70. PubMed ID: 10880169
[TBL] [Abstract][Full Text] [Related]
34. High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.
Dong Q; Liu Z; Chen Y; Chan CY; Lin MC; Kung HF; Chan HL; Sung JJ; He ML
J Virol Methods; 2009 Aug; 159(2):135-40. PubMed ID: 19490966
[TBL] [Abstract][Full Text] [Related]
35. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns.
Pan XB; Wei L; Chen HS; Liu F; Gao Y
Arch Virol; 2007; 152(6):1159-73. PubMed ID: 17308979
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HBV replication by delivering the dual-gene expression vector pHsa-miR16-siRNA in HepG2.2.15 cells.
Wei W; Wang SF; Yu B; Ni M
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):828-832. PubMed ID: 29270739
[TBL] [Abstract][Full Text] [Related]
38. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
Shin D; Kim SI; Kim M; Park M
Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
[TBL] [Abstract][Full Text] [Related]
39. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA.
Ren XR; Zhou LJ; Luo GB; Lin B; Xu A
J Viral Hepat; 2005 May; 12(3):236-42. PubMed ID: 15850463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
